newsfilter
← Latest News
GlobeNewswire·

Molecular Templates' Presentations at the 2022 ASCO Annual Meeting Demonstrate Advancement in PD-L1 and HER2 Programs

AUSTIN, Texas, June 06, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (NASDAQ:MTEM, "Molecular Templates" or "MTEM"))) a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeuti